GNMX
Aevi Genomic Medicine, Inc.
GNMX
GNMX
Delisted
GNMX was delisted on the 3rd of February, 2020.
51 hedge funds and large institutions have $10.3M invested in Aevi Genomic Medicine, Inc. in 2017 Q2 according to their latest regulatory filings, with 11 funds opening new positions, 15 increasing their positions, 12 reducing their positions, and 32 closing their positions.
Holders
51
Holders Change
-22
Holders Change %
-30.14%
% of All Funds
1.27%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
11
Increased
15
Reduced
12
Closed
32
Calls
$13K
Puts
$82K
Net Calls
-$69K
Net Calls Change
-$2.26M
Top Buyers
| Name | Market Value | Shares |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
|
AIP
76
Ameritas Investment Partners
Lincoln,
Nebraska
| – | – | -1,299 | Closed |
|
|
BKA
77
Brick & Kyle Associates
Newtown,
Pennsylvania
| – | – | -1,000 | Closed |
|
78
Creative Planning
Overland Park,
Kansas
| – | – | -1,000 | Closed |
|
|
PA
79
Perceptive Advisors
New York
| – | – | -940 | Closed |
|
80
Simplex Trading
Chicago,
Illinois
| – | – | -300 | Closed |
|
81
Citigroup
New York
| – | – | -39 | Closed |
|
|
CG
82
Cutler Group
San Francisco,
California
| – | – | -28 | Closed |
|
|
BC
83
Broadfin Capital
New York
| – | – | – | – |
|
|
DAM
84
DLD Asset Management
New York
| – | – | – | – |
|
|
WVP
85
Worth Venture Partners
Fort Lee,
New Jersey
| – | – | – | – |
|
|
KF
86
Krilogy Financial
St. Louis,
Missouri
| $0 | 300 | +300 | New |
|